Status:
COMPLETED
The Effects of Whey vs. Collagen on MPS
Lead Sponsor:
McMaster University
Conditions:
Aging
Eligibility:
All Genders
60-75 years
Phase:
NA
Brief Summary
With aging there is a natural loss of muscle mass and strength called sarcopenia, which increases the risk of falls and metabolic disease (i.e. Type II diabetes) and decreases the ability to perform a...
Detailed Description
The age-related decline in skeletal muscle mass and strength, termed sarcopenia, is associated with a host of metabolic disease states including, but not limited to, cancer, stroke, microvascular dise...
Eligibility Criteria
Inclusion
- Healthy
- Ambulatory, and able to perform exercise
- Active (\~3500-10,000 steps per day)
Exclusion
- Smoker
- Diabetic
- Chronic conditions
- Consumption of medications known to affect muscle protein synthesis
- Statin myalgia
- Allergy to milk protein
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2019
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT03281434
Start Date
January 1 2018
End Date
August 1 2019
Last Update
February 10 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Exercise Metabolism Research Laboratory, McMaster Univeristy
Hamilton, Ontario, Canada, L8S 4K1
2
Ivor Wynne Center
Hamilton, Ontario, Canada, L8S4K1